Showing results (111-120 of 13,832) with videos related to
Sort By:
Pageof 1,384
Hepatology (Baltimore, Md.)|November 2, 2010
Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liverGerald U Denk, Silvia Maitz, Ralf Wimmer, et al.Hepatology (Baltimore, Md.)|November 2, 2010
Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicityJoanna D Stewart, Rita Horvath, Enrico Baruffini, et al.Hepatology (Baltimore, Md.)|August 1, 1990
Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver diseaseA Lobo-Yeo, G Senaldi, B Portmann, et al.Hepatology (Baltimore, Md.)|September 1, 1990
Plexiform neurofibromatosis of the liver and mesentery in a childJ S Partin, B P Lane, J C Partin, et al.Hepatology (Baltimore, Md.)|January 22, 2011
Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment responseJama M Darling, Jeroen Aerssens, Gregory Fanning, et al.Hepatology (Baltimore, Md.)|January 22, 2011
Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patientsZheng Zhang, Shuye Zhang, Zhengsheng Zou, et al.Hepatology (Baltimore, Md.)|January 22, 2011
p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathwaysJing Fu, Yao Chen, Jie Cao, et al.Hepatology (Baltimore, Md.)|January 22, 2011
Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infectionMichael R Charlton, Alexander Thompson, Bart J Veldt, et al.Hepatology (Baltimore, Md.)|January 22, 2011
Hepatitis C pharmacogenetics: state of the art in 2010Nezam H Afdhal, John G McHutchison, Stefan Zeuzem, et al.Hepatology (Baltimore, Md.)|January 22, 2011
Endocannabinoids in liver diseaseJoseph Tam, Jie Liu, Bani Mukhopadhyay, et al.Pageof 1,384